Science Explorer Back to mapMap
Discussion
Nonprofit · Newcastle · Australia

Breast Cancer Trials

breastcancertrials.org.auROR OpenAlex
Research works
39
▼ 5% vs 2018-21
Citations
2.6k
68.2 per fractional work
Top-10% rate
12.0%
all institutions 10.0%
Open access
42%
world 40%
International
44%
world 18%
Breast Cancer Trials

Not ranked overall: Breast Cancer Trials is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Breast Cancer Trials work in?

In all years, 57% of research at Breast Cancer Trials is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (51%), Biochemistry, Genetics and Molecular Biology (35%), Health Professions (6%). It does 2.1× the world's share of Health Sciences.

Health Sciences: 22 fractional works · 56.8% of its workMedicine: 20 fractional works · 51.2% of its workOncology: 7 fractional works · 18.4% of its workPulmonary and Respiratory Medicine: 4 fractional works · 11.4% of its workSurgery: 2 fractional works · 5.4% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 4.1% of its workPathology and Forensic Medicine: 2 fractional works · 3.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.9% of its workGastroenterology: 0 fractional works · 0.9% of its workReproductive Medicine: 0 fractional works · 0.6% of its workGeriatrics and Gerontology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.8% of its workHealth Professions: 2 fractional works · 5.6% of its workGeneral Health Professions: 2 fractional works · 5.6% of its workLife Sciences: 14 fractional works · 36.4% of its workBiochemistry, Genetics and Molecular Biology: 14 fractional works · 35.2% of its workCancer Research: 8 fractional works · 20.5% of its workGenetics: 4 fractional works · 9.4% of its workMolecular Biology: 2 fractional works · 5.2% of its workImmunology and Microbiology: 0 fractional works · 1.0% of its workImmunology: 0 fractional works · 1.0% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.2% of its workPharmacology: 0 fractional works · 0.2% of its workSocial Sciences: 2 fractional works · 6.0% of its workEconomics, Econometrics and Finance: 2 fractional works · 4.5% of its workEconomics and Econometrics: 2 fractional works · 4.5% of its workPsychology: 0 fractional works · 1.0% of its workClinical Psychology: 0 fractional works · 1.0% of its workSocial Sciences: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.1% of its workPhysical Sciences: 0 fractional works · 0.8% of its workMathematics: 0 fractional works · 0.4% of its workStatistics and Probability: 0 fractional works · 0.4% of its workComputer Science: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workALL ITS WORKBreast CancerTrials39fractional works, all years
Life Sciences36%Physical Sciences1%Health Sciences57%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 13 fields, with their numbers
    1. Medicine2051.2%
    2. Health Professions25.6%
    1. Biochemistry, Genetics and Molecular Biology1435.2%
    2. Immunology and Microbiology01.0%
    3. Pharmacology, Toxicology and Pharmaceutics00.2%
    1. Economics, Econometrics and Finance24.5%
    2. Psychology01.0%
    3. Social Sciences00.3%
    4. Decision Sciences00.1%
    1. Mathematics00.4%
    2. Computer Science00.3%
    3. Materials Science00.1%
    4. Physics and Astronomy00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.65× its world share, 1 worksBiochemistry, Geneti…Computer Science: 0.08× its world share, 0 worksComputer ScienceMaterials Science: 0.14× its world share, 0 worksMaterials ScienceHealth Professions: 1.43× its world share, 0 worksHealth ProfessionsMedicine: 3.13× its world share, 3 worksMedicineDecision Sciences: 0.85× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.27× its world share, 0 worksEconomics, Econometr…Psychology: 2.15× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.7×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology4.65×1 works
  2. Medicine3.13×3 works
  3. Psychology2.15×0 works
  4. Health Professions1.43×0 works
  5. Economics, Econometrics and Finance1.27×0 works
  6. Decision Sciences0.85×0 works
  7. Materials Science0.14×0 works
  8. Computer Science0.08×0 works

What are the most cited papers from Breast Cancer Trials?

The most cited paper from Breast Cancer Trials is "Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011" (Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al., 2011), with 3,932 citations. Next come "Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013" (3,776) and "Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" (2,067).

Most cited papers
#PaperReleasedCitations
1 Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Aron Goldhirsch, W. C. Wood, Alan Stuart Coates et al. · Annals of Oncology Open access 28 Jun 2011 3,932
2 Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Aron Goldhirsch et al. · Annals of Oncology Open access 6 Aug 2013 3,776
3 Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies et al. · The Lancet Open access 5 Dec 2012 2,067
4 Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology Open access 4 May 2015 1,865
5 Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial Viviana Enrica Galimberti et al. · The Lancet Oncology Open access 10 Mar 2013 1,247
All 60 most cited papers, with filters and sorting

Which keywords describe research at Breast Cancer Trials?

By fractional works in all years, weighted toward what it does more of than the world: Breast Cancer, Radiotherapy, Gene Expression, Clinical Practice Guidelines, Molecular Subtypes, Survival Analysis, Prognostic Markers and Breast Tumours.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Breast Cancer10▲ 91×10 topics
  2. Radiotherapy8▲ 57×6 topics
  3. Gene Expression8▲ 33×6 topics
  4. Clinical Practice Guidelines7▲ 33×4 topics
  5. Molecular Subtypes7▲ 207×2 topics
  6. Survival Analysis7▲ 67×3 topics
  7. Prognostic Markers7▲ 188×2 topics
  8. Breast Tumours7▲ 361×1 topic
  9. Treatment Response7▲ 361×1 topic
  10. Quality of Life6▲ 12×6 topics
  11. Metastatic Breast Cancer5▲ 187×2 topics
  12. CDK4/6 Inhibitors3▲ 458×1 topic
  13. Palbociclib3▲ 458×1 topic
  14. Chemotherapy2▲ 9.2×9 topics
  15. Estrogen2▲ 77×2 topics
  16. Receptor2▲ 78×2 topics
  17. Signaling2▲ 50×3 topics
  18. Transcriptional Regulation2▲ 22×2 topics
  19. Glucocorticoids2▲ 97×1 topic
  20. Nuclear Receptors2▲ 30×1 topic
  21. Cancer Risk2▲ 20×4 topics
  22. Chemotherapy-Induced Peripheral Neuropathy2▲ 101×1 topic
  23. Genetic Testing2▲ 30×2 topics
  24. Ovarian Cancer2▲ 52×3 topics
  25. Taxanes2▲ 101×1 topic
  26. Precision Medicine2▲ 15×4 topics
  27. Metastatic2▲ 64×2 topics
  28. Trastuzumab2▲ 94×2 topics
  29. BRCA12▲ 150×1 topic
  30. BRCA22▲ 150×1 topic
  31. Cancer Survivorship2▲ 64×2 topics
  32. Complications2▲ 7.8×3 topics
  33. EGFR2▲ 131×1 topic
  34. HER22▲ 131×1 topic
  35. Biopsy1▲ 52×2 topics
  36. Clinical Trials1▲ 5.9×8 topics
  37. Health-related Quality of Life1▲ 16×2 topics
  38. Cost-effectiveness Analysis1▲ 44×1 topic
  39. Health Utility Measures1▲ 44×1 topic
  40. Anxiety1▲ 8.8×1 topic

Which research topics does Breast Cancer Trials publish most on?

By volume in 2022-now: Breast Cancer Treatment Studies, Breast Implant and Reconstruction, Advanced Breast Cancer Therapies and Body Image and Dysmorphia Studies.

Breast Cancer Treatment …1Breast Cancer Treatment Studies: 1 fractional worksBreast Implant and Recon…0Breast Implant and Reconstruction: 0 fractional worksAdvanced Breast Cancer T…0Advanced Breast Cancer Therapies: 0 fractional worksBody Image and Dysmorphia Studies: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional worksDigital Imaging in Medicine: 0 fractional worksBRCA gene mutations in cancer: 0 fractional worksCancer survivorship and care: 0 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional works
Cancer ResearchSurgeryPulmonary and Respiratory MedicineClinical Psychology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Breast Cancer Treatment Studies Cancer Research 1 works
  2. 2 Breast Implant and Reconstruction Surgery 0 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  4. 4 Body Image and Dysmorphia Studies Clinical Psychology 0 works
  5. 5 Cancer Treatment and Pharmacology Oncology 0 works
  6. 6 Digital Imaging in Medicine Public Health, Environmental and Occupational Health 0 works
  7. 7 BRCA gene mutations in cancer Genetics 0 works
  8. 8 Cancer survivorship and care Oncology 0 works
  9. 9 HER2/EGFR in Cancer Research Oncology 0 works
  10. 10 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.0%not open58.0%

World: 40% of research is openly available.

with international co-authors44.3%domestic only55.7%

World: 18% is written across borders.

How has Breast Cancer Trials's research output changed?

Output in 2022-2025 was 5% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Breast Cancer Trials as a percentage of every work published that year, 0.000016% in 2024.

still counting0.00010%0.00020%0.00030%Breast Cancer Trials0.000015% in 2025200020102020

Fractional works of Breast Cancer Trials over all fractional works that year. How the balance of science has shifted.

Other research institutions in Newcastle

All research institutions in Newcastle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Breast Cancer Trials. Posts are plain text and can be reported.